50% of the company's profits will be allocated for dividends and distributed among the investors in proportion to their shares.
Each product sale, including the licence fee, which is independent of the production method, will generate income for investors. At the same time, the increase in sales volumes contributes to the growth of investors' returns.
Investing in the MLC project with this dividend model can be a lucrative source of passive income.
Follow the company's development and make informed decisions!
Link to the post with a detailed calculation of dividends: https://my.mlc.health/en/site/newsinfo/2329
